That asthmatics benefit not only from physical exercise but that they can even reach performance levels comparable to that of non asthmatics is becoming increasingly clear. To reach such a level, asthmatics need to use drugs to prevent effort-related asthma attacks in addition to taking appropriate therapeutic measures. We must conclude that the dose needed to obtain this effect is higher than that used for therapeutic purposes in asthma or respiratory diseases. Bearing in mind that oral treatments are considerably less effective than inhaled drugs in exercise-related asthma attacks, that the doses of the latter are lower and that the ergogenic effects of the substances studied are nil or below detection levels, it seems logical to allow individuals with asthma who use such substances to engage in physical exercise. ISSN:

Author:Arashura Nikolabar
Language:English (Spanish)
Published (Last):12 April 2018
PDF File Size:16.95 Mb
ePub File Size:9.51 Mb
Price:Free* [*Free Regsitration Required]

Para maiores detalhes, veja a Figura 1. Cienc Saude Coletiva. Schainfeld RM. Management of peripheral arterial disease and intermittent claudication. J Am Board Fam Pract. Prevalence and risk factors associated with peripheral arterial disease in the Hearts of Brazil Project.

Arq Bras Cardiol. An obligation for primary care physicians to prescribe physical activity to sedentary patients to reduce the risk of chronic health conditions. Mayo Clin Proc. Zanesco A, Antunes E. Effects of exercise training on the cardiovascular system: pharmacological approaches. Pharmacol Ther. Zago AS, Zanesco A. Nitric oxide: cardiovascular disease and physical exercise. The role of exercise training in peripheral arterial disease. Vasc Med. The reliability of walking tests in people with claudication.

Am J Phys Med Rehabil. Comparative study of evolution and survival of patients with intermittent claudication, with or without limitation for exercises, followed in a specific outpatient setting.

J Vasc Bras. Dawson DL. Comparative effects of cilostazol and other therapies for intermittent claudication. Am J Cardiol. Impaired microvascular endothelial function is restored by acute lower-limb exercise in post-surgical varicose vein patients. Microvasc Res. State-of-the-Art lecture: influence of exercise training on neurogenic control of blood pressure in spontaneously hypertensive rats.

Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.

Webb RC. Smooth muscle contraction and relaxation. Adv Physiol Educ. Barueri: Manole; Arterioscler Thromb Vasc Biol. Wagner CA. Hydrogen sulfide: a new gaseous signal molecule and blood pressure regulator.

J Nephrol. Langer SZ. Presynaptic regulation of catecholamine release. Biochem Pharmacol. Starke K. Alpha-adrenoceptor subclassification. Rev Physiol Biochem Pharmacol. Alpha 1-adrenoceptor classification: sharpening Occam's razor. Trends Pharmacol Sci. Preserved sensitivity to beta2-adrenergic receptor agonists in patients with type 1 diabetes mellitus and hypoglycemia unawareness.

J Clin Endocrinol Metab. Differential effect of isoproterenol on acute glucagon and insulin release in man. Nonogaki K. New insights into sympathetic regulation of glucose and fat metabolism. Regional and gender variations in adipose tissue lipolysis in response to weight loss. J Lipid Res. Differentiation of receptors responsive to isoproterenol. Life Sci. Molecular characterization of the human beta 3-adrenergic receptor.

Aryl propanolamines: comparison of activity at human beta3 receptors, rat beta3 receptors and rat atrial receptors mediating tachycardia. Br J Pharmacol. Characterization and localization of atypical beta-adrenoceptors in rat ileum. Localization and characterization of two propranolol resistant - [I]cyanopindolol binding sites in rat skeletal muscle.

Eur J Pharmacol. Characterization of propranolol-resistant - -[I]-cyanopindolol binding sites in rat soleus muscle. Kaumann AJ, Molenaar P. Modulation of human cardiac function through 4 beta-adrenoceptor populations. Naunyn Schmiedebergs Arch Pharmacol. Granneman JG. The putative beta4-adrenergic receptor is a novel state of the beta1-adrenergic receptor.

Am J Physiol Endocrinol Metab. Mol Pharmacol. Overexpression of beta 1-adrenoceptors in adult rat ventricular myocytes enhances CGP A cardiostimulation: implications for 'putative' beta 4-adrenoceptor pharmacology. Baker JG. Evidence for a secondary state of the human beta3-adrenoceptor.

Atypical beta-adrenergic effects on insulin signaling and action in beta 3 -adrenoceptor-deficient brown adipocytes. Vascular reactivity in men and women of reproductive age. Am J Obstet Gynecol. Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J Am Coll Cardiol. Guimaraes S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev. Responses to the beta 2-selective agonist procaterol of vascular and atrial preparations with different functional beta-adrenoceptor populations.

Lack of correlation between arterial and venous beta-adrenergic receptor sensitivity. Species differences in the distribution of beta-adrenoceptor subtypes in bladder smooth muscle. Autoradiographic localization of beta-adrenoceptors in pig lung using [I]-iodocyanopindolol.

Role of beta2-adrenoceptors beta-AR , but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-mediated relaxation of rat intrapulmonary artery.

Chiba S, Tsukada M. Vascular responses to beta-adrenoceptor subtype-selective agonists with and without endothelium in rat common carotid arteries. J Auton Pharmacol. Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries.

Differential distribution of beta-adrenergic receptor subtypes in blood vessels of knockout mice lacking beta 1 - or beta 2 -adrenergic receptors. Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol. Studies on the mechanisms underlying beta-adrenoceptor-mediated relaxation of rat abdominal aorta. J Smooth Muscle Res. Nihon Kokyuki Gakkai Zasshi. Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cyclic adenosine monophosphate-dependent pathway.

Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cAMP-dependent pathway. Biochem Biophys Res Commun. Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta. Shafiei M, Mahmoudian M. Atypical beta-adrenoceptors of rat thoracic aorta.


Receptor adrenérgico beta 1




Related Articles